Clinical trial

Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

NCT00346840 · Ferring Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00346840
Title Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour
Official title Controlled-Release Misoprostol Vaginal Insert in Parous Women for Labor Induction: Randomized Trial
Lead sponsor Ferring Pharmaceuticals, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Labor Induction, Cervical Ripening
Intervention type Drug
Interventions Misoprostol vaginal insert 25 mcg, Misoprostol vaginal insert 50 mcg, Misoprostol vaginal insert 100 mcg, Misoprostol vaginal insert 200 mcg
Enrollment 124
Start date Jun 1, 2003
Primary completion Feb 1, 2004
Completion Mar 1, 2004
First posted Jun 30, 2006
Last update posted Jun 18, 2012
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies